Home › Funds › PKO BP BANKOWY Universal Pension Society JSC › NBIX

PKO BP BANKOWY Universal Pension Society JSC position in NBIX

NEUROCRINE BIOSCIENCES INC · Health Care

PKO BP BANKOWY Universal Pension Society JSC reported holding 170,802 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$24.2M, representing 7.13% of its reported portfolio and ranking #5 among its reported holdings. PKO BP BANKOWY Universal Pension Society JSC has disclosed NBIX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)170.80K sh
Reported value held$24.23M
Portfolio Weight7.13%
First reportedQ4 2024
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How PKO BP BANKOWY Universal Pension Society JSC's NBIX position evolved

PKO BP BANKOWY Universal Pension Society JSC first disclosed a stake in NBIX in Q4 2024 at 128,802 shares (US$17.6M). The position peaked in Q2 2026 at 170,802 shares, worth US$28.8M. Across 8 filings, PKO BP BANKOWY Universal Pension Society JSC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 170,802 shares valued at US$24.2M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 128.80K $17.58M New
Q1 2025 138.80K $15.35M Add
Q2 2025 138.80K $17.45M Hold
Q3 2025 138.80K $19.49M Hold
Q4 2025 138.80K $19.69M Hold
Q1 2026 138.80K $18.29M Hold
Q2 2026 170.80K $28.79M Add
Q3 2026 170.80K $24.23M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBIX and 13F data

NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 34 other funds we track also report a position in NBIX — the largest reported positions include Renaissance Technologies (US$393.7M), Two Sigma Investments (US$349.9M), Vestal Point Capital, LP (US$316.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBIX

All NBIX fund holders →

FAQ

How long has PKO BP BANKOWY Universal Pension Society JSC held NBIX?

PKO BP BANKOWY Universal Pension Society JSC has disclosed NBIX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is PKO BP BANKOWY Universal Pension Society JSC's current position in NBIX?

As of Q3 2026, PKO BP BANKOWY Universal Pension Society JSC holds 170.80K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $24.23M, representing 7.13% of its reported portfolio and ranking #5.

Has PKO BP BANKOWY Universal Pension Society JSC been buying or selling NBIX?

In the latest 13F filing (Q3 2026), PKO BP BANKOWY Universal Pension Society JSC held unchanged its position in NBIX. The position peaked in Q2 2026 at 170.80K shares.

Which other funds hold NBIX?

Other major institutional holders of NBIX include Renaissance Technologies, Two Sigma Investments, Vestal Point Capital, LP, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.